Enhancing remote monitoring and classification of motor state in Parkinson’s disease using Wearable Technology and Machine Learning
暂无分享,去创建一个
L. Ferrigno | L. Rochester | A. Yarnall | L. Alcock | S. D. Din | G. Cerro | C. Carissimo | Alessandro Marino | T. D. Libero | H. Debelle | E. Packer
[1] A. Rodio,et al. Technological support for people with Parkinson’s disease: a narrative review , 2022, Journal of Gerontology and Geriatrics.
[2] L. Ferrigno,et al. Development and Assessment of a Movement Disorder Simulator Based on Inertial Data , 2022, Sensors.
[3] L. Ferrigno,et al. Parkinson's disease aided diagnosis: online symptoms detection by a low-cost wearable Inertial Measurement Unit , 2022, 2022 IEEE International Symposium on Medical Measurements and Applications (MeMeA).
[4] C. Mazzà,et al. Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol , 2022, medRxiv.
[5] K. Demestichas,et al. Internet of Things Technologies and Machine Learning Methods for Parkinson’s Disease Diagnosis, Monitoring and Management: A Systematic Review , 2022, Sensors.
[6] B. Eskofier,et al. Do We Walk Differently at Home? A Context-Aware Gait Analysis System in Continuous Real-World Environments , 2021, 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC).
[7] J. Hausdorff,et al. Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead , 2021, Journal of Parkinson's disease.
[8] Max A. Little,et al. Real-Life Gait Performance as a Digital Biomarker for Motor Fluctuations: The Parkinson@Home Validation Study , 2020, Journal of medical Internet research.
[9] P. M. Pradhan,et al. A Supervised Machine Learning Approach to Detect the On/Off State in Parkinson’s Disease Using Wearable Based Gait Signals , 2020, Diagnostics.
[10] Bernd Bischl,et al. High-Resolution Motor State Detection in Parkinson’s Disease Using Convolutional Neural Networks , 2020, Scientific Reports.
[11] B. Mollenhauer,et al. Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide , 2020, Movement disorders clinical practice.
[12] M. Okun,et al. Diagnosis and Treatment of Parkinson Disease: A Review. , 2020, JAMA.
[13] J. Bronstein,et al. PKG Movement Recording System Use Shows Promise in Routine Clinical Care of Patients With Parkinson's Disease , 2019, Front. Neurol..
[14] V. Boleková,et al. Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication , 2019, Front. Neurol..
[15] Lynn Rochester,et al. Gait analysis with wearables predicts conversion to Parkinson disease , 2019, Annals of neurology.
[16] Benedict Michael,et al. Faculty Opinions recommendation of Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[17] Murtadha D. Hssayeni,et al. Deep Learning for Medication Assessment of Individuals with Parkinson’s Disease Using Wearable Sensors , 2018, 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
[18] Richard P. Martin,et al. A Review of Medication Adherence Monitoring Technologies , 2018 .
[19] B. Galna,et al. Free-living gait characteristics in ageing and Parkinson’s disease: impact of environment and ambulatory bout length , 2016, Journal of NeuroEngineering and Rehabilitation.
[20] Alan Godfrey,et al. Validation of an Accelerometer to Quantify a Comprehensive Battery of Gait Characteristics in Healthy Older Adults and Parkinson's Disease: Toward Clinical and at Home Use , 2016, IEEE Journal of Biomedical and Health Informatics.
[21] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[22] P. Lewitt,et al. Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics , 2015, Movement disorders : official journal of the Movement Disorder Society.
[23] Joan Cabestany,et al. Dyskinesia and motor state detection in Parkinson's Disease patients with a single movement sensor , 2012, 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[24] Angelo Antonini,et al. Levodopa in the treatment of Parkinson’s disease: an old drug still going strong , 2010, Clinical interventions in aging.
[25] Talia Herman,et al. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers. , 2009, Gait & posture.
[26] Paolo Bonato,et al. Monitoring Motor Fluctuations in Patients With Parkinson's Disease Using Wearable Sensors , 2009, IEEE Transactions on Information Technology in Biomedicine.
[27] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.
[28] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[29] Tianjian Ji,et al. FREQUENCY AND VELOCITY OF PEOPLE WALKING , 2005 .
[30] R. Hauser,et al. Parkinson's disease home diary: Further validation and implications for clinical trials , 2004, Movement disorders : official journal of the Movement Disorder Society.
[31] Alan M Jette,et al. Late life function and disability instrument: I. Development and evaluation of the disability component. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[32] A. H. Rajput,et al. Levodopa prolongs life expectancy and is non-toxic to substantia nigra. , 2001, Parkinsonism & related disorders.
[33] Wolzt,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, The Journal of the American College of Dentists.
[34] L. Fried,et al. Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[35] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[36] Alan Godfrey,et al. Detecting free-living steps and walking bouts: validating an algorithm for macro gait analysis , 2017, Physiological measurement.
[37] S. Fahn. The history of dopamine and levodopa in the treatment of Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.